Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Argus Health
US Army
McKesson
Chinese Patent Office

Generated: July 16, 2019

DrugPatentWatch Database Preview

Patent: 9,618,514

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,618,514
Title:Methods of evaluating patients using E-cadherin and vimentin
Abstract: Methods for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
Inventor(s): Choe; Sung Eun (Lexington, MA), Hurov; Jonathan (Cambridge, MA), Ulanet; Danielle (Cambridge, MA)
Assignee: AGIOS PHARMACEUTICALS, INC (Cambridge, MA)
Application Number:14/428,456
Patent Claims:see list of patent claims

Details for Patent 9,618,514

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Try a Free Trial AGIOS PHARMACEUTICALS, INC (Cambridge, MA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Express Scripts
US Army
Citi
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.